http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010508253-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
filingDate | 2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2010508253-A |
titleOfInvention | DMAE as the only drug used to treat mild cognitive impairment |
abstract | The present invention provides a free or salt or ester form as the only active ingredient for the manufacture of a medicament for use in the treatment of non-dementia mild cognitive impairment characterized by hippocampal amnesia syndrome, It further relates to the use of dimethylaminoethanol (DMAE) in the form of its hydrates and solvates. |
priorityDate | 2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.